Related Experiment Video
Updated: Aug 23, 2025
07:31
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
8.1K
Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder
1Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, Scripps Research Institute, La Jolla, California.
Alcohol Research : Current Reviews
|November 2, 2022
Summary
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) celebrates 50 years as a leading funder of alcohol research. NIAAA advances diagnosis, prevention, and treatment of alcohol use disorder through innovative research.
Area of Science:
- Neuroscience
- Public Health
- Medical Research
Background:
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) was established in 1970.
- NIAAA is the world's largest funding agency for alcohol research.
- NIAAA supports basic, translational, and clinical research for alcohol use disorder.
Purpose of the Study:
- Commemorate the 50th anniversary of NIAAA.
- Highlight advancements in alcohol research over 50 years.
- Showcase evidence-based diagnosis, prevention, and treatment strategies.
Main Methods:
- Review of NIAAA's research funding and programs.
- Summary of presentations from the "Alcohol Across the Lifespan" symposium.
- Based on a presentation by Dr. Mason.
Main Results:
- NIAAA has significantly advanced the understanding and treatment of alcohol-related problems.
- The institute supports a wide spectrum of research, from basic science to clinical applications.
- Key topics in alcohol research were discussed at the anniversary symposium.
Conclusions:
- NIAAA has been instrumental in driving progress in alcohol research.
- Continued investment in research is crucial for addressing alcohol use disorder.
- The symposium underscored the importance of evidence-based approaches in the field.
More Related Videos
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
327
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
327
01:23Antidepressant Drugs: MAOIs and Other Agents
307
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
307
01:28Drug Therapy
89
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
89
01:28Depressants
165
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
165
01:22Alzheimer's Disease: Treatment
246
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
246
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
229
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
229